Lexaria Bioscience Corp. (LEXX)
1.13
+0.04
(+3.67%)
USD |
NASDAQ |
Dec 09, 16:00
1.13
0.00 (0.00%)
After-Hours: 20:00
Lexaria Bioscience Total Assets (Quarterly): 4.175M for Aug. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | 10.82M |
| Aurinia Pharmaceuticals, Inc. | 527.53M |
| Edesa Biotech, Inc. | 14.80M |
| Xenon Pharmaceuticals, Inc. | 607.84M |
| ProMIS Neurosciences, Inc. | 21.46M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.572M |
| Shareholders Equity (Quarterly) | 2.990M |
| Debt to Equity Ratio | 0.0366 |
| Current Ratio | 2.322 |
| Net Debt Paydown Yield | 0.04% |